Glucose-6-phosphate dehydrogenase deficiency risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(5 intermediate revisions by one other user not shown)
Line 5: Line 5:
{{CMG}}; {{AE}} {{MA}}
{{CMG}}; {{AE}} {{MA}}
==Overview==
==Overview==
There are no established risk factors for [disease name].
Common risk factors in the development of G6PD deficiency include some foods such as [[Fava bean|fava]] beans, some [[Medication|medications]] and [[Infection|infections]].
 
OR
 
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
 
OR
 
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
 
OR
 
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.


==Risk Factors==
==Risk Factors==


The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
Common risk factors in the development of G6PD deficiency include some foods such as [[Fava bean|fava]] beans, some [[Medication|medications]] and [[Infection|infections]].  
 
OR
 
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
===Common Risk Factor===
===Common Risk Factor===
*Common risk factors in the development of G6PD include:
*Common risk factors in the development of G6PD include:
**Foods such as fava beans in G6PD mutation carriers
**Foods such as [[Fava bean|fava]] beans in G6PD [[mutation]] carriers
**Medications such as:
**Medications <ref name="pmid29262208">{{cite journal |vauthors=Richardson SR, O'Malley GF |title= |journal= |volume= |issue= |pages= |date= |pmid=29262208 |doi= |url=}}</ref>
***Aspirin  
***[[Aspirin]]
***Antimalarials: quinine, primaquine, pamaquine, and chloroquine
***[[Antimalarial drug|Antimalarials]]: [[quinine]], [[primaquine]], [[pamaquine]], and [[chloroquine]]
***Sulfonamides: mafenide, sulfanilamide, sulfamethoxazole
***[[Sulfonamides]]: [[mafenide]], [[sulfanilamide]], [[sulfamethoxazole]]
***Thiazolesulfone
***Thiazolesulfone
***Methylene blue
***Methylene blue
***Analgesics: phenazopyridine and acetanilide
***[[Analgesic|Analgesics]]: [[phenazopyridine]] and [[acetanilide]]
***Rasburicase
***[[Rasburicase]]
***Some non-sulfa antibiotics : furazolidone, isoniazid, dapsone, nalidixic acid, nitrofurantoin). Henna has been known to cause hemolytic crisis in G6PD-deficient infants. Rasburicase is also contraindicated in G6PD deficiency. High dose intravenous vitamin C has also been known to cause haemolysis in G6PD deficiency carriers, thus G6PD deficiency testing is routine before infusion of doses of 25g or more.
***Some non-sulfa antibiotics such as  [[furazolidone]], [[isoniazid]], [[dapsone]], [[nalidixic acid]], [[nitrofurantoin]]).
***High dose [[vitamin C]]
***
***
**Bacterial, viral and rickettsial infection
**[[Bacterial]], [[viral]] and [[rickettsial]] infection
**Some chemicals: Hanna in tattos and hair dyes.<ref name="pmid11668106">{{cite journal |vauthors=Raupp P, Hassan JA, Varughese M, Kristiansson B |title=Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency |journal=Arch. Dis. Child. |volume=85 |issue=5 |pages=411–2 |date=November 2001 |pmid=11668106 |pmc=1718961 |doi= |url=}}</ref>  
**Some chemicals: Hanna in tattos and hair dyes<ref name="pmid11668106">{{cite journal |vauthors=Raupp P, Hassan JA, Varughese M, Kristiansson B |title=Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency |journal=Arch. Dis. Child. |volume=85 |issue=5 |pages=411–2 |date=November 2001 |pmid=11668106 |pmc=1718961 |doi= |url=}}</ref>  
**  
**  
===Less Common Risk Factors===
===Less Common Risk Factors===
*Less common risk factors in the development of G6PD include:
*Less common risk factors in the development of G6PD include:
**Moth balls (naphthalene)
**Moth balls ([[naphthalene]])
**
**
**Diabetic ketoacidosis<ref name="pmid4623682">{{cite journal |vauthors=Gellady AM, Greenwood RD |title=G-6-PD hemolytic anemia complicating diabetic ketoacidosis |journal=J. Pediatr. |volume=80 |issue=6 |pages=1037–8 |date=June 1972 |pmid=4623682 |doi= |url=}}</ref>
**[[Diabetic ketoacidosis]]<ref name="pmid4623682">{{cite journal |vauthors=Gellady AM, Greenwood RD |title=G-6-PD hemolytic anemia complicating diabetic ketoacidosis |journal=J. Pediatr. |volume=80 |issue=6 |pages=1037–8 |date=June 1972 |pmid=4623682 |doi= |url=}}</ref>
**Amyl nitrite or isobutyl nitrite in RUSH ( sexual enhancement drug)<ref name="pmid8081534">{{cite journal |vauthors=Beaupre SR, Schiffman FJ |title=Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use |journal=Arch Fam Med |volume=3 |issue=6 |pages=545–8 |date=June 1994 |pmid=8081534 |doi= |url=}}</ref>
**[[Amyl nitrite]] or [[isobutyl nitrite]] in RUSH ( sexual enhancement drug)<ref name="pmid8081534">{{cite journal |vauthors=Beaupre SR, Schiffman FJ |title=Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use |journal=Arch Fam Med |volume=3 |issue=6 |pages=545–8 |date=June 1994 |pmid=8081534 |doi= |url=}}</ref>
**
**


Line 56: Line 41:
{{WS}}
{{WS}}
[[Category: (name of the system)]]
[[Category: (name of the system)]]
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com]
Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How to Edit a Page|here]]  to learn about editing.
==Overview==
==Risk Factors==
* Ethnic groups
** African American
** Middle Eastern decent, particularly Kurdish or Sephardic Jewish
* Male
* Family history of the deficiency
==References==
{{reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Disease]]
[[Category:Hematology]]
[[Category:Mature chapter]]
[[Need content]]

Latest revision as of 13:41, 17 October 2018


Glucose-6-phosphate dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glucose-6-phosphate dehydrogenase deficiency risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glucose-6-phosphate dehydrogenase deficiency risk factors

CDC on Glucose-6-phosphate dehydrogenase deficiency risk factors

Glucose-6-phosphate dehydrogenase deficiency risk factors in the news

Blogs on Glucose-6-phosphate dehydrogenase deficiency risk factors

Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency

Risk calculators and risk factors for Glucose-6-phosphate dehydrogenase deficiency risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]

Overview

Common risk factors in the development of G6PD deficiency include some foods such as fava beans, some medications and infections.

Risk Factors

Common risk factors in the development of G6PD deficiency include some foods such as fava beans, some medications and infections.

Common Risk Factor

Less Common Risk Factors

References

  1. Richardson SR, O'Malley GF. PMID 29262208. Missing or empty |title= (help)
  2. Raupp P, Hassan JA, Varughese M, Kristiansson B (November 2001). "Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency". Arch. Dis. Child. 85 (5): 411–2. PMC 1718961. PMID 11668106.
  3. Gellady AM, Greenwood RD (June 1972). "G-6-PD hemolytic anemia complicating diabetic ketoacidosis". J. Pediatr. 80 (6): 1037–8. PMID 4623682.
  4. Beaupre SR, Schiffman FJ (June 1994). "Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use". Arch Fam Med. 3 (6): 545–8. PMID 8081534.

Template:WH Template:WS